Vanguard Group’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.91M | Sell |
|
|||||
|
2025
Q1 | $5.24M | Sell |
|
|||||
|
2024
Q4 | $6.25M | Sell |
|
|||||
|
2024
Q3 | $13.9M | Sell |
|
|||||
|
2024
Q2 | $19.4M | Buy |
|
|||||
|
2024
Q1 | $29.9M | Sell |
|
|||||
|
2023
Q4 | $26.4M | Sell |
|
|||||
|
2023
Q3 | $24.9M | Buy |
|
|||||
|
2023
Q2 | $53.7M | Buy |
|
|||||
|
2023
Q1 | $30.1M | Buy |
|
|||||
|
2022
Q4 | $43.7M | Buy |
|
|||||
|
2022
Q3 | $90.9M | Buy |
|
|||||
|
2022
Q2 | $69.3M | Buy |
|
|||||
|
2022
Q1 | $44.3M | Buy |
|
|||||
|
2021
Q4 | $16.6M | Sell |
|
|||||
|
2021
Q3 | $32.7M | Buy |
|
|||||
|
2021
Q2 | $28.4M | Buy |
|